Topical application of ALA and ALA hexyl ester on a subcutaneous murine mammary adenocarcinoma: Tissue distribution

British Journal of Cancer

Volumn 88, Issue 3, 2003, Pages 432-437

  Perotti, C ^a   Casas, A ^a   Fukuda, H ^a   Sacca, P ^a   Batlle, A ^a,b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE   (Argentina)

Author keywords

ALA derivatives (ALA hexyl ester); Aminolevulinic acid (ALA); Photodynamic therapy (PDT)

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID HEXYL ESTER; ANTINEOPLASTIC AGENT; DIMETHYL SULFOXIDE; DRUG VEHICLE; ESTER DERIVATIVE; PROTOPORPHYRIN; UNCLASSIFIED DRUG; WATER OIL CREAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER; BRAIN; BREAST ADENOCARCINOMA; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG MECHANISM; EAR; HEART; INTESTINE; LOTION; LUNG; MALE; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SKIN; SUBCUTANEOUS TISSUE; TISSUE DISTRIBUTION; TUMOR GROWTH;

ADMINISTRATION, TOPICAL; AMINOLEVULINIC ACID; ANIMALS; DISEASE MODELS, ANIMAL; ESTERS; FEMALE; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; PHOTOSENSITIZING AGENTS; PORPHYRINS; SKIN NEOPLASMS; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0037428706     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600665     Document Type: Article

References (27)

1. Batlle A (1997) Porfirias y Porfirinas. Aspectos clínicos, bioquímicos y biología molecular. ED: Acta Bioquímica Clínica Latinoamericana, Buenos Aires Argentina
2. Cairnduff F, Springer M, Hudson EJ, Ash DV, Brown SB (1994) Superficial photodynamic therapy with topical 5-aminolevulinic acid for superficial primary and secondary skin cancer. Br J Cancer 69: 605-608
3. Casas A, Batlle A, Butler A, Robertson D, Brown E, MacRobert A, Riley P (1999a) Comparative effect of ALA derivatives on Protoporphyrin IX production in human and rat skin organ cultures. Br J Cancer 80: 1525-1532
4. Casas A, Fukuda H, Batlle A (1999b) Tissue distribution and kinetics of endogenous porphyrins synthesized after topical application of ALA in different vehicles. Br J Cancer 81: 13-18.
5. Casas A, Fukuda H, Di Venosa G, Battle A (2000) The influence of the vehicle on the synthesis of porphyrins after topical application of 5-aminolevulinic acid. Implications in cutaneous photodynamic sensitization. Br J Dermatol 143: 1-10.
6. Casas A, Fukuda H, Di Venosa G, Batlle A (2001a) Photosensitisation and mechanism of cytotoxicity induced by the use of ALA derivatives in photodynamic therapy. Br J Cancer 85: 279-284
7. Casas A, Perotti C, Fukuda H, Rogers L, Butler A, Batlle A (2001b) ALA and ALA hexyl ester-induced porphyrin synthesis in chemically induced skin tumours: the role of different vehicles on improving photosensitisation. Br J Cancer 85(11): 1794-1800
8. Fritsch C, Homey B, Stahl W, Lehemann P, Ruzicka T, Sies H (1998) Preferential relative porphyrin enrichment in solar keratoses upon topical application of 5-aminolevulinic acid methyl ester. Photochem Photobiol 68: 218-221
9. Galli S, Colombo L, Vanzuli S, Daroqui M, Vidal M, Jasnis A, Lustig E, Eiján A. (2000). Characterization of a fibroblastoid mammary carcinoma cell line (LM2) originated from a mouse adenocarcinoma. Int J Oncol 17: 1259-1265
10. Gaullier JM, Berg K, Peng Q, Anholt H, Selbo PK, Ma LW, Moan J (1997) Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. Cancer Res 57: 1481-1486
11. Henderson BW, Dougherty TJ (1992) How does photodynamic therapy work? Photochem Photobiol 55: 145-157
12. Kennedy JC, Marcus SL, Pottier RH (1996) Photodynamic therapy and photodiagnosis using endogenous photosensitization induced by 5-aminolevulinic acid: mechanisms and clinical results. J Clin Laser Med Surg 14: 289-304
13. Kennedy JC, Pottier RH, Pross DC (1990) Photodynamic therapy with endogenous protoporphyrin IX: basic principles and basic clinical experience. J Photochem Photobiol B: Biol 6: 143-148
14. Kloek J, Beijersbergen van Henegouwen GMJ (1996) Prodrugs of 5-aminolevulinic acid for photodynamic therapy. Photochem Photobiol 64: 994-1000
15. Lange N, Jichlinski P, Zellweger M, Forrer M, Marti A, Guillo L, Kucera P, Wagnieres GA, van den Bergh H (1999) Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexylester induced protoporphyrin IX: a pilot study. Br J Cancer 80: 185-193
16. Malik Z, Kostenich G, Roitman L et al (1995) Topical application of 5-aminolevulinic acid, DMSO and EDTA. Protoporphyrin accumulation in skin and tumours mice. J Photochem Photobiol B Biol 28: 213-218
17. Marti A, Lange N, van den Bergh H, Sedmera D, Jichlinski P, Kucera P (1999) Optimisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach. J Urol 162: 546-552
18. Moan J, Ma L, Iani V (2001) On the pharmacokinetics of topically applied 5-aminolevulinic acid and two of its esters. Int J Cancer 92: 139-143
19. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM (1997) 5-Aminolevulinic acid-based photodynamic therapy: principles and experimental research. Photochem Photobiol 65: 235-251
20. Peng Q, Moan J, Warloe T, Iani V, Steen H, Bjørseth A, Nesland J (1996) Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. J Photochem Photobiol B Biol 34: 95-96
21. Peng Q, Warloe T, Moan J, Heyerdahl H, Steen HB, Nesland JM, Giercksky KE (1995) Distribution of 5-aminolevulinic acid-induced porphyrins in nodulo-ulcerative basal cell carcinomas. Photochem Photobiol 62: 906-913
22. Perotti C, Casas A, Fukuda H, Sacca P, Batlle A (2002) ALA and ALA hexyl ester induction of porphyrins after systemic administration to tumour bearing mice. Br J Cancer 87: 790-795
23. Stoughton R, Fritdch W (1964) Influence of dimethylsulfoxide (DMSO) on human percutaneous absorption. Arch Dermatol 90: 512-517
24. Van der Akker JT, Bruijn HS, Beijersbergen van Henegouwen GMJ, Star WM, Sterenborg HJCM (2000a) Protoporphyrin IX fluorescence kinetics and localization after topical application of ALA pentyl ester and ALA on hairless mouse skin with UVB-induced early skin cancer. Photochem Photobiol 72: 399-406
25. Van der Akker JT, Iani V, Star WM, Sterenborg HJCM, Moan J (2000b) Topical application of 5-aminolevulinic acid hexyl ester and 5-aminolevulinic to normal nude mouse skin: differences in protoporphyrin IX fluorescence kinetics and the role of the stratum corneum. Photochem Photobiol 72: 681-689
26. Wiechers J (1989) The barrier function of the skin in relation to percutaneous absorption of drugs. Pharm Weekbl Sci 11: 185-198
27. Workman P, Balmain A, Hickman JA, Mc Nally NJ, Rohas AM, Mitchison NA, Pierrepoint CG, Laymond R, Stephers TC et al (1998) UK-Coordinating Committee on Cancer Research. UKCCCR Guidelines for the Welfare of Animals in Experimental Neoplasia, 2nd ed. Lab Anim 22: 195-201